Objective: This study aimed to discriminate group A β-hemolytic streptococcus (GABHS) and Epstein-Barr virus (EBV) that cause acute tonsillopharyngitis with a new index called the infection discrimination index (IDI).
Material and Methods: Based on the throat culture and viral capsid Ag Ig M results, 110 GABHS-positive children and 52 EBV-positive children were enrolled in the GABHS and EBV groups, respectively. Fifty children who had undergone a medical examination at the pediatric clinic comprised the control group. The IDI means of the three groups (GABHS, EBV, control) were subjected to a statistical comparison.
Results: The groups did not significantly differ in terms of sex and age (p: 0.453 and 0.662, respectively). The IDI means of the three groups were significantly different (p<0.001). Receiver operating characteristic (ROC) analysis was performed to calculate the sensitivity and specificity of IDI in the GABHS and EBV groups. The ROC analysis demonstrated a sensitivity of 68.2% and specificity of 92% for predicting GABHS infection. The sensitivity and specificity was 53.8% and 96%, respectively, for predicting EBV infection.
Conclusion: IDI calculated from the data of complete blood count can serve as a biomarker for discriminating between GABHS and EBV infections. We believe that the findings of this study would be particularly helpful for centers where throat culture and/or antibody tests cannot be performed. It is a rapid, practical, noninvasive, and cost-effective index.
Tonsillitis pharyngitis infectious mononucleosis streptococcus pyogenes Epstein-Barr virus infections index
| Primary Language | English |
|---|---|
| Subjects | Otorhinolaryngology |
| Journal Section | Research Article |
| Authors | |
| Publication Date | December 20, 2020 |
| DOI | https://doi.org/10.5152/ejra.2020.333 |
| IZ | https://izlik.org/JA36XL48KM |
| Published in Issue | Year 2020 Volume: 3 Issue: 3 |
You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104
Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.